NCT05873322View on ClinicalTrials.gov

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Precursor Cell Lymphoblastic Leukemia-LymphomaDrug-Induced Diabetes MellitusImpaired Glucose ToleranceLymphoma
Trial Locations (1)

8200

RECRUITING

Aarhus University Hospital, Aarhus N

All Listed Sponsors
lead

Aarhus University Hospital

OTHER